Delivery Order SPE2DB20D2014-SPE2DB24FC62E
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,941,013 units of Dapagliflozin 10 mg tablets, a prescription medication. The order has a ceiling value of $3,969.09 and a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,468,045 units of the pharmaceutical product Dapagliflozin 10 mg Tablets. The contract has a ceiling value of $13,780.10 and an ultimate completion date of August 16, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,254,962 units of the pharmaceutical drug dapagliflozin 10 mg tablets. The award has a ceiling value of $25,926.70 and a completion date of July 26, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical products to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,825,260 units of dapagliflozin 5 mg tablets. The contract has a ceiling value of $1,588.40 and a completion date of September 17, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will supply these essential prescription medications to support various federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,232,835 units of the pharmaceutical drug dapagliflozin 10 mg tablet in 30-count packages. The award has a ceiling value of $1,202.59 and a period of performance through May 14, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a $1,224.71 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,840 units of dapagliflozin 10 mg tablets. The contract has a period of performance through September 18, 2024 and was awarded on September 17, 2022. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,961.68, is for the delivery of 4,568,120 units of the prescription medication dapagliflozin 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,376.58 contract is for the supply of 4,567,951,816 units of the diabetes medication Dapagliflozin 10 mg tablets. The award has an ultimate completion date of April 18, 2025 and is not a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,077,688 tablets of the medication dapagliflozin 10 mg. The $5,948.05 firm fixed-price contract has an ultimate completion date of April 30, 2025 and is not a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.68 firm fixed-price contract is for the delivery of dapagliflozin 10 mg tablets. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...